Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 7 November 2000
Vol. 2000, Issue 57, p. tw9
[DOI: 10.1126/stke.2000.57.tw9]


Cancer The Facts on Bax

Many anticancer agents kill tumor cells by inducing apoptosis, and improvements in therapeutic strategies will depend on a clear understanding of the molecular mechanisms by which this occurs. To study the role of the Bax protein in drug-induced apoptosis, Zhang et al. used sophisticated genetic approaches to create derivatives of human colorectal cancer cells that were devoid of functional Bax genes. Cells without Bax retained a partial apoptotic response to the chemotherapeutic agent 5-fluorouracil but were completely resistant to apoptosis induced by nonsteroidal anti-inflammatory drugs (NSAIDs), agents currently being used clinically for cancer chemoprevention. This striking requirement for Bax in the cellular response to NSAIDs may have important implications for future cancer chemoprevention strategies, because it suggests that cells can easily develop resistance to this class of drugs.

Zhang, L., Yu, J., Park, B.H., Kinzler, K.W., and Vogelstein, B. (2000) Role of BAX in the apoptotic response to anticancer agents. Science 290: 989-992. [Abstract] [Full Text]

Citation: The Facts on Bax. Sci. STKE 2000, tw9 (2000).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882